Hep C Drug Stocks in the Spotlight

Description:

According to Adam Feuerstein, "Biotech and drug investors with interest in emerging treatments for hepatitis C turn their attention this week to the European Association for the Study of the Liver (EASL) annual meeting, which kicks off Weds. March 30." Read more here.

>>Also: Top-Rated Biotech Stocks

>>Also: 40 Stocks Analysts Are Insanely Bullish About

Most Viewed Portfolios

View All

Articles

4 Big Stocks to Trade (or Not)

08.29.14 | 02:50 PM

BALTIMORE (Stockpickr) -- Put down the 10-K filings and the stock screeners. It's time to take a break from the traditional methods of generating ...

3 Tech Stocks on Traders' Radars

08.29.14 | 02:57 PM

BALTIMORE (Stockpickr) -- Put down the 10-K filings and the stock screeners. It's time to take a break from the traditional methods of generating ...

More Articles
blog comments powered by Disqus
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter